ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Net Income ContractionContracting
Percentile Rank60
3Y CAGR-25.9%
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

3Y CAGR
-25.9%/yr
vs -9.6%/yr prior
Acceleration
-16.3pp
Decelerating
Percentile
P60
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$188.68M-81.1%
2025$996.57M+8.1%
2024$921.66M+99.0%
2023$463.18M+2473.8%
2022$-19.51M+98.3%
2021$-1.17B+11.1%
2020$-1.31B-288.8%
2019$694.08M+119.7%
2018$-3.53B+28.8%
2017$-4.95B-